WallStreetZenWallStreetZen

NASDAQ: AYTU
Aytu Biopharma Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Aytu Biopharma revenue was $57.57M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $16.1M, up 29.8% from last quarter. For the last reported fiscal year 2026 ending Jun 30, 2026, AYTU annual revenue was $57.6M, with -13.3% growth year-over-year.

AYTU past revenue growth

How has AYTU's revenue growth performed historically?

Company
-13.27%
Industry
33.92%
Market
32.87%
AYTU's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AYTU's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AYTU's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AYTU revenue history

Current Revenue
$57.6M
Current Earnings
-$14.3M
Current Profit Margin
-24.8%

Be the first to know when AYTU announces revenue.

AYTU Revenue History By Year

AYTU Yearly RevenueAYTU RevenueAYTU ChangeAYTU Revenue Growth
2026-06-30$57.57M-$8.81M-13.27%
2025-06-30$66.38M$1.20M+1.84%
2024-06-30$65.18M-$8.62M-11.67%
2023-06-30$73.80M-$22.87M-23.66%
2022-06-30$96.67M$31.04M+47.29%
2021-06-30$65.63M$38.00M+137.52%
2020-06-30$27.63M$20.31M+277.47%
2019-06-30$7.32M$3.66M+100.00%
2018-06-30$3.66M$438.53k+13.61%
2017-06-30$3.22M$659.15k+25.72%
2016-06-30$2.56M$2.30M+878.85%
2015-06-30$261.78k$202.85k+344.23%
2014-06-30$58.93kN/AN/A

1 of 1

Aytu Biopharma Revenue FAQ

What was AYTU's revenue last quarter?

On Sep 22, 2026, Aytu Biopharma (NASDAQ: AYTU) reported Q2 2026 revenue of $16.11 million up 6.42% year over year. In the same quarter last year, Aytu Biopharma's revenue was $15.14 million.

What was Aytu Biopharma's revenue in 2026?

Aytu Biopharma's annual revenue for the twelve months ending Jun 30, 2026 was $57.57 million, a 13.27% decrease year over year.

How much does Aytu Biopharma make in a day?

Based on Aytu Biopharma annual revenue for the past five years, AYTU makes an average of $197,042.74 per day.

What was Aytu Biopharma's annual revenue growth in the past year?

As of Q4 2026, Aytu Biopharma's revenue has grown -13.27% year over year. This is 47.2 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 33.92%. Aytu Biopharma's revenue in the past year totaled $57.57 million.

How much does Aytu Biopharma make in a year?

Aytu Biopharma's revenue by year for the past five years is:
  • Aytu Biopharma's revenue for the twelve months ending Jun 30, 2026 was $57.57 million, a 13.27% decrease year over year.
  • Aytu Biopharma's annual revenue for Jun 30, 2025 was $66.38 million, a 1.84% increase from 2024.
  • Aytu Biopharma's annual revenue for 2024 was $65.18 million, a 11.67% decrease from 2023.
  • Aytu Biopharma's annual revenue for 2023 was $73.80 million, a 23.66% decrease from 2022.
  • Aytu Biopharma's annual revenue for 2022 was $96.67 million, a 47.29% increase from 2021.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.